Search results

Found 2,264 pages
AUTHOR: Lynne Taylor

30 Aug 2007:

UK pharma code “needs to be toughened”

The UK Prescription Medicines Code of Practice Authority (PCMPA) has come under strong criticism for the way it scrutinises drugmakers’ compliance with the industry’s system of self-regulation. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/uk_pharma_code_needs_to_be_toughened_990742

17 Dec 2013:

GSK to end payments to doctors

Early next year, GlaxoSmithKline (GSK) will begin a consultation on ending direct payments to healthcare professionals for speaking on its behalf to audiences who can prescribe or influence prescribing. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/gsk_to_end_payments_to_doctors_1006197

3 Jan 2012:

"Choose your GP" pilots announced

Health Secretary Andrew Lansley has announced that one-year pilot schemes for a new initiative which will allow patients to choose their GP practice will begin in April. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/choose_your_gp_pilots_announced_975969

14 Oct 2013:

California governor vetoes biosimilars law

California Governor Gerry Brown has vetoed legislation designed to regulate the use of biosimilar drugs in the state. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/california_governor_vetoes_biosimilars_law_1005838

20 Aug 2014:

Biosimilars: US concerns growing

61% of respondents to a survey of physicians who prescribe biologics and biosimilars in Europe believe that if two products share an international nonproprietary name, they are approved for all of the same indications. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/biosimilars_us_concerns_growing_1002353

7 Sep 2009:

EU pledge to India over drug seizures

The European Commission has told India it will take steps to end the seizures of Indian-made generic drugs at EU ports, but would prefer not to do so through a legal battle at the World Trade Organization (WTO). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/eu_pledge_to_india_over_drug_seizures_983696

4 Apr 2014:

NICE U-turn on Roche's Tarceva

The National Institute for Health and Care Excellence (NICE) has issued revised draft guidance reversing its decision to restrict access to Roche’s Tarceva (erlotinib) in patients with second-line non-small cell lung cancer (NSCLC). - News -

by Lynne Taylor

https://www.pharmatimes.com/news/nice_u-turn_on_roches_tarceva_1001774

4 Sep 2012:

NHS data accuracy: still room for improvement

The quality of data being used by the NHS Payment by Results (PbR) system has improved since last year, but the performance of individual NHS Acute Trusts varies each year, according to the Audit Commission. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/nhs_data_accuracy_still_room_for_improvement_976702

23 Aug 2012:

Venezuela: concerns over pharma imports

Venezuelan government officials have announced moves which will, say industry sources, make the importing of finished and bulk pharmaceutical products a lengthier and more difficult process. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/venezuela_concerns_over_pharma_imports_976757

6 Aug 2008:

MHRA: new procedure for company name changes

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced a new procedure for companies that intend to change their name. The changes will not only apply to companies or legal entities which hold authorisations under the UK

by Lynne Taylor

https://www.pharmatimes.com/news/mhra_new_procedure_for_company_name_changes_988132